Breaking News Instant updates and real-time market news.

$COMP

Nasdaq Composite

$0.00 /

+ (+0.00%)

08:20
11/03/20
11/03
08:20
11/03/20
08:20

Nasdaq Composite: Pivot points

The following are the pivot points for the Nasdaq Composite ($COMP). Pivot High: 11014.345, Pivot Low: 10774.215. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.

TODAY'S FREE FLY STORIES

Hot Stocks
Johnson & Johnson sees no biosimilar entrants in Pharmaceutical segment FY21  09:20
01/26/21
01/26
09:20
01/26/21
09:20
JNJ

Johnson & Johnson

$165.91 /

+2.23 (+1.36%)

 
ShowHide Related Items >><<
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

Recommendations
AMC Entertainment's capital raise results in massive dilution, says Loop Capital » 09:20
01/26/21
01/26
09:20
01/26/21
09:20
AMC

AMC Entertainment

/

+

Loop Capital analyst Alan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMC AMC Entertainment
/

+

AMC AMC Entertainment
/

+

08:09 Today B. Riley Securities
AMC Entertainment price target raised to $5.50 from $3.50 at B. Riley Securities
12/28/20 B. Riley Securities
'Wonder Women' opens well above expectations, says B. Riley Securities
12/04/20 B. Riley Securities
Theater selloff on Warner Bros. news likely an overreaction, says B. Riley
11/03/20 B. Riley Securities
AMC Entertainment price target lowered to $3.50 from $4.50 at B. Riley Securities
AMC AMC Entertainment
/

+

AMC AMC Entertainment
/

+

AMC AMC Entertainment
/

+

AMC AMC Entertainment
/

+

Initiation
5N Plus initiated with a Strong Buy at Raymond James » 09:19
01/26/21
01/26
09:19
01/26/21
09:19
FPLSF

5N Plus

$0.00 /

+ (+0.00%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FPLSF 5N Plus
$0.00 /

+ (+0.00%)

01/13/21 National Bank
5N Plus price target raised to C$4 from C$2.90 at National Bank
Conference/Events
DIA to hold a virtual conference » 09:19
01/26/21
01/26
09:19
01/26/21
09:19
ABBV

AbbVie

$110.26 /

-0.6 (-0.54%)

, ALXN

Alexion

$161.30 /

+1.55 (+0.97%)

, AZN

AstraZeneca

$54.02 /

+0.76 (+1.43%)

, BIIB

Biogen

$275.38 /

+6.16 (+2.29%)

, BMY

Bristol-Myers

$64.82 /

+0.26 (+0.40%)

, ESALY

Eisai

$0.00 /

+ (+0.00%)

, HALO

Halozyme

$48.78 /

-0.73 (-1.47%)

, IQV

Iqvia

$182.87 /

-3.04 (-1.64%)

, LLY

Eli Lilly

$212.52 /

+6.22 (+3.02%)

, MSFT

Microsoft

$229.34 /

+3.45 (+1.53%)

Pharmacovigilance &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABBV AbbVie
$110.26 /

-0.6 (-0.54%)

ALXN Alexion
$161.30 /

+1.55 (+0.97%)

AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

BIIB Biogen
$275.38 /

+6.16 (+2.29%)

BMY Bristol-Myers
$64.82 /

+0.26 (+0.40%)

ESALY Eisai
$0.00 /

+ (+0.00%)

HALO Halozyme
$48.78 /

-0.73 (-1.47%)

IQV Iqvia
$182.87 /

-3.04 (-1.64%)

LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

MSFT Microsoft
$229.34 /

+3.45 (+1.53%)

ABBV AbbVie
$110.26 /

-0.6 (-0.54%)

01/06/21 RBC Capital
AbbVie named one of top stocks to own in 2021 by RBC Capital
12/17/20 Stifel
Outcome in Evolus IP case 'better than most investors expected,' says Stifel
12/16/20 SVB Leerink
AbbVie price target raised to $128 from $119 at SVB Leerink
12/15/20 Mizuho
AbbVie price target raised to $117 from $111 at Mizuho
ALXN Alexion
$161.30 /

+1.55 (+0.97%)

01/08/21 Raymond James
Alexion downgraded to Market Perform from Outperform at Raymond James
12/16/20 Truist
Alexion downgraded to Hold from Buy at Truist
12/15/20 Truist
Argenx price target raised to $350 from $275 at Truist
12/14/20 Citi
Alexion downgraded to Neutral from Buy at Citi
AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

01/22/21 Barclays
AstraZeneca price target lowered to 9,000 GBp from 9,300 GBp at Barclays
01/19/21 BTIG
Adaptive Biotechnologies price target raised to $74 from $66 at BTIG
01/15/21 Berenberg
AstraZeneca price target lowered to 10,000 GBp from 10,500 GBp at Berenberg
01/15/21
Fly Intel: Top five analyst initiations
BIIB Biogen
$275.38 /

+6.16 (+2.29%)

01/14/21 Truist
Truist says FDA wouldn't be discussing label if not going to approve aducanumab
01/11/21 Goldman Sachs
Eli Lilly's Alzheimer's trial data a 'positive surprise,' says Goldman Sachs
12/04/20 Mizuho
Sage Therapeutics upgraded to Buy from Neutral at Mizuho
12/01/20 Truist
Sage Therapeutics price target raised to $70 from $60 at Truist
BMY Bristol-Myers
$64.82 /

+0.26 (+0.40%)

01/20/21 William Blair
Exelixis selloff on competitive concerns an 'overreaction,' says William Blair
01/20/21 Citi
Citi opens 'negative Catalyst Watch' on Bristol-Myers
12/15/20 Goldman Sachs
Bristol-Myers upgraded to Conviction Buy from Buy at Goldman Sachs
12/09/20 Mizuho
Pentwater seeks to replace Bristol-Myers Squibb CVR trustee, says Mizuho
ESALY Eisai
$0.00 /

+ (+0.00%)

01/20/21 William Blair
Exelixis selloff on competitive concerns an 'overreaction,' says William Blair
11/05/20 Jefferies
Eisai upgraded to Buy from Hold at Jefferies
09/08/20 Jefferies
Eisai downgraded to Hold from Buy at Jefferies
HALO Halozyme
$48.78 /

-0.73 (-1.47%)

01/25/21 BMO Capital
Halozyme price target raised to $65 from $56 at BMO Capital
01/21/21 Benchmark
Halozyme price target raised to $59 from $46 at Benchmark
01/14/21 Piper Sandler
Halozyme price target raised to $50 from $42 at Piper Sandler
01/11/21 Benchmark
Phesgo EU approval/Horizon deal fuel Halozyme increased guidance, says Benchmark
IQV Iqvia
$182.87 /

-3.04 (-1.64%)

12/18/20 Mizuho
Iqvia price target raised to $200 from $190 at Mizuho
10/22/20 Deutsche Bank
Iqvia price target raised to $196 from $180 at Deutsche Bank
10/21/20 UBS
Iqvia price target raised to $224 from $204 at UBS
10/21/20 Morgan Stanley
Iqvia price target raised to $195 from $182 at Morgan Stanley
LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

01/20/21 Citi
Citi opens 'positive Catalyst Watch' on Eli Lilly into Alzheimer's data
01/19/21 Roth Capital
Merus price target raised to $32 from $19 at Roth Capital
01/19/21
Fly Intel: Top five analyst upgrades
01/19/21 Mizuho
Eli Lilly upgraded to Buy from Neutral at Mizuho
MSFT Microsoft
$229.34 /

+3.45 (+1.53%)

01/25/21 Raymond James
Microsoft assumed with a Strong Buy at Raymond James
01/25/21 Morgan Stanley
Morgan Stanley says market closer to recognizing Alphabet sum-of-the-parts value
01/25/21 DA Davidson
Box downgraded to Neutral from Buy at DA Davidson
01/22/21 RBC Capital
Varonis price target raised to $200 from $165 at RBC Capital
ABBV AbbVie
$110.26 /

-0.6 (-0.54%)

ALXN Alexion
$161.30 /

+1.55 (+0.97%)

AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

BIIB Biogen
$275.38 /

+6.16 (+2.29%)

BMY Bristol-Myers
$64.82 /

+0.26 (+0.40%)

HALO Halozyme
$48.78 /

-0.73 (-1.47%)

IQV Iqvia
$182.87 /

-3.04 (-1.64%)

LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

MSFT Microsoft
$229.34 /

+3.45 (+1.53%)

ABBV AbbVie
$110.26 /

-0.6 (-0.54%)

ALXN Alexion
$161.30 /

+1.55 (+0.97%)

AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

BIIB Biogen
$275.38 /

+6.16 (+2.29%)

BMY Bristol-Myers
$64.82 /

+0.26 (+0.40%)

LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

MSFT Microsoft
$229.34 /

+3.45 (+1.53%)

ABBV AbbVie
$110.26 /

-0.6 (-0.54%)

ALXN Alexion
$161.30 /

+1.55 (+0.97%)

AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

BIIB Biogen
$275.38 /

+6.16 (+2.29%)

BMY Bristol-Myers
$64.82 /

+0.26 (+0.40%)

ESALY Eisai
$0.00 /

+ (+0.00%)

HALO Halozyme
$48.78 /

-0.73 (-1.47%)

IQV Iqvia
$182.87 /

-3.04 (-1.64%)

LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

MSFT Microsoft
$229.34 /

+3.45 (+1.53%)

ALXN Alexion
$161.30 /

+1.55 (+0.97%)

BIIB Biogen
$275.38 /

+6.16 (+2.29%)

ABBV AbbVie
$110.26 /

-0.6 (-0.54%)

ALXN Alexion
$161.30 /

+1.55 (+0.97%)

AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

BIIB Biogen
$275.38 /

+6.16 (+2.29%)

BMY Bristol-Myers
$64.82 /

+0.26 (+0.40%)

LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

MSFT Microsoft
$229.34 /

+3.45 (+1.53%)

Hot Stocks
Draganfly's Vital Intelligence Technology selected by The 517 Group » 09:19
01/26/21
01/26
09:19
01/26/21
09:19
DFLYF

Draganfly

$0.00 /

+ (+0.00%)

Draganfly announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DFLYF Draganfly
$0.00 /

+ (+0.00%)

DFLYF Draganfly
$0.00 /

+ (+0.00%)

Hot Stocks
Seanergy joins 'Neptune Declaration on Seafarer Wellbeing and Crew Change' » 09:18
01/26/21
01/26
09:18
01/26/21
09:18
SHIP

Seanergy Marine

$1.20 /

+0.225 (+23.20%)

Seanergy Maritime…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SHIP Seanergy Marine
$1.20 /

+0.225 (+23.20%)

SHIP Seanergy Marine
$1.20 /

+0.225 (+23.20%)

07/08/20 Maxim
Seanergy Marine downgraded to Hold from Buy at Maxim
07/08/20 Maxim
Seanergy Marine downgraded to Hold from Buy at Maxim
SHIP Seanergy Marine
$1.20 /

+0.225 (+23.20%)

  • 18
    Aug
Hot Stocks
FedEx Ground CEO Maier to retire July 31, John Smith to succeed » 09:18
01/26/21
01/26
09:18
01/26/21
09:18
FDX

FedEx

$253.43 /

-0.965 (-0.38%)

FedEx announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FDX FedEx
$253.43 /

-0.965 (-0.38%)

FDX FedEx
$253.43 /

-0.965 (-0.38%)

01/07/21 Wolfe Research
FedEx downgraded to Peer Perform from Outperform at Wolfe Research
12/30/20 Argus
FedEx price target raised to $305 from $270 at Argus
12/18/20 Raymond James
FedEx price target raised to $305 from $280 at Raymond James
12/18/20 Morgan Stanley
FedEx's 'modest' Q2 beat likely falls short of high bar, says Morgan Stanley
FDX FedEx
$253.43 /

-0.965 (-0.38%)

FDX FedEx
$253.43 /

-0.965 (-0.38%)

FDX FedEx
$253.43 /

-0.965 (-0.38%)

FDX FedEx
$253.43 /

-0.965 (-0.38%)

Options
Overnight activity included 1053 trades in SPX and 29 trades in VIX » 09:18
01/26/21
01/26
09:18
01/26/21
09:18
SPX

S&P 500

$0.00 /

+ (+0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00 /

+ (+0.00%)

1053 trades were executed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPX S&P 500
$0.00 /

+ (+0.00%)

SPX S&P 500
$0.00 /

+ (+0.00%)

01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
VIX Volatility Index S&P 500 Options
$0.00 /

+ (+0.00%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPX S&P 500
$0.00 /

+ (+0.00%)

VIX Volatility Index S&P 500 Options
$0.00 /

+ (+0.00%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Hot Stocks
Dakota Territory Resource acquires Black Hills property » 09:17
01/26/21
01/26
09:17
01/26/21
09:17
DTRC

Dakota Territory Resource

$0.00 /

+ (+0.00%)

Dakota Territory Resource…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DTRC Dakota Territory Resource
$0.00 /

+ (+0.00%)

Hot Stocks
Johnson & Johnson sees FY21 adjusted pre-tax operating margin up ~200 bps  09:16
01/26/21
01/26
09:16
01/26/21
09:16
JNJ

Johnson & Johnson

$165.91 /

+2.23 (+1.36%)

 
ShowHide Related Items >><<
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

Hot Stocks
Northrop Grumman awarded $3.6B ID/IQ BACN pact from U.S. Air Force » 09:16
01/26/21
01/26
09:16
01/26/21
09:16
NOC

Northrop Grumman

$299.34 /

+0.84 (+0.28%)

The U.S. Air Force…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NOC Northrop Grumman
$299.34 /

+0.84 (+0.28%)

NOC Northrop Grumman
$299.34 /

+0.84 (+0.28%)

01/07/21 Baird
Northrop Grumman downgraded to Neutral from Outperform at Baird
12/09/20 Noble Capital
Kratos Defense price target raised to $26 from $23 at Noble Capital
11/03/20 Morgan Stanley
Morgan Stanley sees attractive buying opportunity in Defense stocks
10/13/20 Credit Suisse
Northrop Grumman price target lowered to $390 from $400 at Credit Suisse
NOC Northrop Grumman
$299.34 /

+0.84 (+0.28%)

NOC Northrop Grumman
$299.34 /

+0.84 (+0.28%)

NOC Northrop Grumman
$299.34 /

+0.84 (+0.28%)

Recommendations
Schlumberger price target raised to $30 from $24 at Argus » 09:15
01/26/21
01/26
09:15
01/26/21
09:15
SLB

Schlumberger

$23.75 /

-0.645 (-2.64%)

Argus analyst Bill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SLB Schlumberger
$23.75 /

-0.645 (-2.64%)

SLB Schlumberger
$23.75 /

-0.645 (-2.64%)

01/25/21
Fly Intel: Top five analyst upgrades
01/25/21 BofA
Schlumberger upgraded to Buy from Neutral at BofA
01/25/21 BofA
Schlumberger upgraded to Buy from Neutral at BofA
12/18/20 JPMorgan
Schlumberger price target raised to $21 from $19 at JPMorgan
SLB Schlumberger
$23.75 /

-0.645 (-2.64%)

SLB Schlumberger
$23.75 /

-0.645 (-2.64%)

SLB Schlumberger
$23.75 /

-0.645 (-2.64%)

SLB Schlumberger
$23.75 /

-0.645 (-2.64%)

Conference/Events
Cato Institute to hold a virtual event » 09:15
01/26/21
01/26
09:15
01/26/21
09:15

"Section 230: A Look…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Periodicals
CBS suspends executives accused of creating hostile work environment, NYT says » 09:15
01/26/21
01/26
09:15
01/26/21
09:15
VIACA

ViacomCBS

$47.83 /

+1.79 (+3.89%)

, VIAC

ViacomCBS

$47.70 /

+2.11 (+4.63%)

CBS has suspended two top…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIACA ViacomCBS
$47.83 /

+1.79 (+3.89%)

VIAC ViacomCBS
$47.70 /

+2.11 (+4.63%)

VIACA ViacomCBS
$47.83 /

+1.79 (+3.89%)

01/05/21 Gabelli
ViacomCBS named a best idea for 2021 at Gabelli
07/13/20
Fly Intel: Top five analyst initiations
07/13/20
Fly Intel: Top five analyst downgrades
04/07/20 Barrington
ViacomCBS downgraded to Market Perform from Outperform at Barrington
VIAC ViacomCBS
$47.70 /

+2.11 (+4.63%)

01/21/21 Needham
ViacomCBS price target raised to $55 from $36 at Needham
01/19/21
Fly Intel: Top five analyst downgrades
01/19/21 Barclays
ViacomCBS downgraded to Underweight from Overweight at Barclays
01/15/21 MoffettNathanson
ViacomCBS price target raised to $50 from $26 at MoffettNathanson
VIACA ViacomCBS
$47.83 /

+1.79 (+3.89%)

VIAC ViacomCBS
$47.70 /

+2.11 (+4.63%)

VIACA ViacomCBS
$47.83 /

+1.79 (+3.89%)

VIAC ViacomCBS
$47.70 /

+2.11 (+4.63%)

VIACA ViacomCBS
$47.83 /

+1.79 (+3.89%)

VIAC ViacomCBS
$47.70 /

+2.11 (+4.63%)

VIAC ViacomCBS
$47.70 /

+2.11 (+4.63%)

Hot Stocks
EnWave announces Merck publication citing EnWave's freezeREV process » 09:15
01/26/21
01/26
09:15
01/26/21
09:15
NWVCF

EnWave

$0.00 /

+ (+0.00%)

, MRK

Merck

$81.15 /

+0.19 (+0.23%)

EnWave Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NWVCF EnWave
$0.00 /

+ (+0.00%)

MRK Merck
$81.15 /

+0.19 (+0.23%)

NWVCF EnWave
$0.00 /

+ (+0.00%)

12/14/20 Raymond James
EnWave price target raised to C$1.60 from C$1.20 at Raymond James
04/24/20 Raymond James
EnWave downgraded to Market Perform from Outperform at Raymond James
MRK Merck
$81.15 /

+0.19 (+0.23%)

01/21/21 Wedbush
Scholar Rock price target raised to $66 from $47 at Wedbush
01/20/21 William Blair
Exelixis selloff on competitive concerns an 'overreaction,' says William Blair
01/20/21 Citi
Citi opens 'negative Catalyst Watch' on Bristol-Myers
01/06/21 Citi
Citi opens 'positive catalyst watch' on Merck
NWVCF EnWave
$0.00 /

+ (+0.00%)

MRK Merck
$81.15 /

+0.19 (+0.23%)

MRK Merck
$81.15 /

+0.19 (+0.23%)

MRK Merck
$81.15 /

+0.19 (+0.23%)

MRK Merck
$81.15 /

+0.19 (+0.23%)

General news
U.S. S&amp;P Case Shiller home price index increased 1.1% to 238.5 in November » 09:15
01/26/21
01/26
09:15
01/26/21
09:15

U.S. S&amp;P Case…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
ExOne to 3D print lightweight ceramic-metal parts » 09:13
01/26/21
01/26
09:13
01/26/21
09:13
XONE

ExOne

$24.58 /

+2.05 (+9.10%)

The ExOne Company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XONE ExOne
$24.58 /

+2.05 (+9.10%)

XONE ExOne
$24.58 /

+2.05 (+9.10%)

01/19/21 Stifel
ExOne initiated with a Buy at Stifel
11/24/20 Oppenheimer
Oppenheimer starts ExOne at Outperform with $13 price target
11/24/20 Oppenheimer
ExOne initiated with an Outperform at Oppenheimer
11/06/20 Alliance Global Partners
Alliance Global downgrades ExOne to Neutral, advises waiting for pullback
XONE ExOne
$24.58 /

+2.05 (+9.10%)

Earnings
Summit State Bank reports Q4 EPS 48c vs. 30c last year » 09:13
01/26/21
01/26
09:13
01/26/21
09:13
SSBI

Summit State Bank

$17.50 /

+0.5 (+2.94%)

"In 2020 we continue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SSBI Summit State Bank
$17.50 /

+0.5 (+2.94%)

Recommendations
Regions Financial price target raised to $20 from $15 at Argus » 09:12
01/26/21
01/26
09:12
01/26/21
09:12
RF

Regions Financial

$17.71 /

-0.02 (-0.11%)

Argus analyst Kevin Heal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RF Regions Financial
$17.71 /

-0.02 (-0.11%)

RF Regions Financial
$17.71 /

-0.02 (-0.11%)

01/25/21 Citi
Regions Financial valuation 'becoming more interesting,' says Citi
01/15/21 Compass Point
Regions Financial upgraded to Buy from Neutral at Compass Point
01/12/21 UBS
UBS downgrades Citizens on revenue headwinds, Wells new top pick
01/07/21 Keefe Bruyette
Regions Financial upgraded to Outperform from Market Perform at Keefe Bruyette
RF Regions Financial
$17.71 /

-0.02 (-0.11%)

RF Regions Financial
$17.71 /

-0.02 (-0.11%)

RF Regions Financial
$17.71 /

-0.02 (-0.11%)

RF Regions Financial
$17.71 /

-0.02 (-0.11%)

Conference/Events
The Board of Governors of the Federal Reserve System to hold a closed meeting » 09:11
01/26/21
01/26
09:11
01/26/21
09:11

The Board of Governors of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Aurora Cannabis closes bought deal financing » 09:11
01/26/21
01/26
09:11
01/26/21
09:11
ACB

Aurora Cannabis

$10.16 /

-0.49 (-4.60%)

Aurora Cannabis closed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACB Aurora Cannabis
$10.16 /

-0.49 (-4.60%)

ACB Aurora Cannabis
$10.16 /

-0.49 (-4.60%)

01/06/21 BMO Capital
Federal cannabis reform in U.S. likely to take time, says BMO Capital
12/17/20 BMO Capital
Aurora Cannabis downgraded to Underperform from Market Perform at BMO Capital
12/04/20 Alliance Global Partners
Alliance Global sees low odds of MORE Act passing this congressional session
12/02/20 Alliance Global Partners
Alliance Global Partners sees UN cannabis reclassification helping legalization
ACB Aurora Cannabis
$10.16 /

-0.49 (-4.60%)

  • 22
    Jan
  • 11
    Nov
ACB Aurora Cannabis
$10.16 /

-0.49 (-4.60%)

ACB Aurora Cannabis
$10.16 /

-0.49 (-4.60%)

ACB Aurora Cannabis
$10.16 /

-0.49 (-4.60%)

Earnings
First Choice Bank reports Q4 EPS 92c, one est. 66c » 09:11
01/26/21
01/26
09:11
01/26/21
09:11
FCBP

First Choice Bank

$19.01 /

+0.11 (+0.58%)

Tangible book value per…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FCBP First Choice Bank
$19.01 /

+0.11 (+0.58%)

Hot Stocks
Merck announces new interim data from oral islatravir trial » 09:11
01/26/21
01/26
09:11
01/26/21
09:11
MRK

Merck

$81.15 /

+0.19 (+0.23%)

Merck announced new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$81.15 /

+0.19 (+0.23%)

MRK Merck
$81.15 /

+0.19 (+0.23%)

01/21/21 Wedbush
Scholar Rock price target raised to $66 from $47 at Wedbush
01/20/21 William Blair
Exelixis selloff on competitive concerns an 'overreaction,' says William Blair
01/20/21 Citi
Citi opens 'negative Catalyst Watch' on Bristol-Myers
01/06/21 Citi
Citi opens 'positive catalyst watch' on Merck
MRK Merck
$81.15 /

+0.19 (+0.23%)

MRK Merck
$81.15 /

+0.19 (+0.23%)

MRK Merck
$81.15 /

+0.19 (+0.23%)

MRK Merck
$81.15 /

+0.19 (+0.23%)

Hot Stocks
CyrusOne purchases renewable energy to power Texas data centers » 09:10
01/26/21
01/26
09:10
01/26/21
09:10
CONE

CyrusOne

$72.31 /

+1.31 (+1.85%)

CyrusOne announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CONE CyrusOne
$72.31 /

+1.31 (+1.85%)

CONE CyrusOne
$72.31 /

+1.31 (+1.85%)

12/03/20 Mizuho
Mizuho initiates data center REIT sector with positive outlook
12/02/20 Mizuho
CyrusOne initiated with a Neutral at Mizuho
11/02/20 Deutsche Bank
CyrusOne price target lowered to $80 from $88 at Deutsche Bank
09/23/20 Deutsche Bank
CyrusOne valuation discount to peers unwarranted, says Deutsche Bank
CONE CyrusOne
$72.31 /

+1.31 (+1.85%)

Downgrade
Cleveland-Cliffs downgraded to Hold on 'emerging headwinds' at GLJ Research » 09:09
01/26/21
01/26
09:09
01/26/21
09:09
CLF

Cleveland-Cliffs

$16.58 /

+0.18 (+1.10%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLF Cleveland-Cliffs
$16.58 /

+0.18 (+1.10%)

CLF Cleveland-Cliffs
$16.58 /

+0.18 (+1.10%)

08:47 Today GLJ Research
Cleveland-Cliffs downgraded to Hold from Buy at GLJ Research
01/18/21 Exane BNP Paribas
Cleveland-Cliffs upgraded to Outperform from Neutral at Exane BNP Paribas
01/12/21 B. Riley Securities
Cleveland-Cliffs price target raised to $20 from $16 at B. Riley Securities
12/18/20 GLJ Research
GLJ recommends three long positions with China bulk metals 'booming'
CLF Cleveland-Cliffs
$16.58 /

+0.18 (+1.10%)

CLF Cleveland-Cliffs
$16.58 /

+0.18 (+1.10%)

CLF Cleveland-Cliffs
$16.58 /

+0.18 (+1.10%)

CLF Cleveland-Cliffs
$16.58 /

+0.18 (+1.10%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.